References
- Aas K. Prokonvertin og konvertin. Akad. Trykningssentral, Oslo 1952; 21, Thesis
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346
- Biggs R., Douglas A. S. The thromboplastin generation test. J. clin. Path. 1953; 6: 23
- Biggs R., Macfarlane R. G. Haemophilia and related conditions: A survey of 187 cases. Brit. J. Haemat. 1958; 4: 1
- Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Ark. Kemi 1956; 10: 415
- Borchgrevink C. F., Waaler B. A. The secondary bleeding time. Acta med. scand. 1958; 162: 361
- Egeberg O. Assay of antihemophilic A. B and C factors by one-stage cephalin systems. Scand. J. clin. Lab. Invest. 1961a; 13: 140
- Egeberg O. Acquired circulating anticoagulant in classical hemophilia. Ibid. 1961b; 13: 535
- Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Ibid. 1957; 9, Suppl. 27
- Hjort P. F., Rapaport S. I., Owren P. A. A simple one-stage prothrombin assay using Russell's viper venom in cephalin suspension. J. Lab. clin. Med. 1955; 46: 89
- Hjort P. F., Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest. 1957; 9, Suppl. 29
- Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Ibid. 1955; 7, Suppl. 14
- Langdell R. D., Wagner R. H., Brinkhous K. M. Effect of antihemophilic factor on onestage clotting tests. J. Lab. clin. Med. 1953; 41: 637
- Nyegaard K. Direct method of counting platelets in oxalated blood. Proc. Mayo Clin. 1933; 8: 365
- Owren P. A. The coagulation of blood. Investigations on a new clotting factor. Acta med. scand. 1947; 128, Suppl. 194
- Owren P. A., Aas K. The control of dicoumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
- Ratnoff O. D., Margolius A. Hageman trait: An asymptomatic disorder of blood coagulation. Trans. Ass. Amer. Phycns 1955; 68: 149
- Rosenthal R. L., Dreskin O. H., Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc. Soc. exp. Biol. (N.Y.) 1953; 82: 171
- Stapp W. F. A one-stage method for the assay of antihemophilic factor B (AHF B), with a comment on the antihemophilic B (AHF B) concentration in phenylindanedione (PID) therapy. Scand. J. clin. Lab. Invest. 1958; 10: 169
- Stefanini M., Dameshek W. A clinical and therapeutic approach. The hemorrhagic disorders. Grune & Stratton, New York 1955
- Todd M., Panter G., Wright I. S. New blood clotting factors. Transactions of the conference of the International Commitee on blood clotting factors, Montreux, Switzerland, 1959. Schattauer, Stuttgart 1960
- Voss D. Untersuchungen zur Gerinnsel-Retraktion. Proc. VII Congr. int. Soc. Haemat. 1958; 346
- Waaler B. A. Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scand. J. clin. Lab. Invest. 1957; 9: 322
- Waaler B. A. Contact activation in the intrinsic blood clotting system. Ibid. 1959a; 11, Suppl. 37
- Waaler B. A. A simple one-stage method for the assay of antihemophilic A factor. with a comment on the plasma level of this factor in hemophilia A. Ibid. 1959b; 11: 194